Grace Larry
Directeur/Bestuurslid bij Generate Biomedicines, Inc.
Profiel
Grace Larry is currently a Senior Director at Generate Biomedicines, Inc. and a Venture Partner at Alix Ventures.
Prior to his current roles, he worked as an Executive Director at Amgen, Inc. from 2019 to 2021 and as a Director-Asia Operations at Novartis AG from 2011 to 2013.
Mr. Larry has a graduate degree from the University of California, Berkeley, an MBA from Kellogg School of Management, and a graduate degree from Northwestern University School of Law.
Actieve functies van Grace Larry
Bedrijven | Functie | Begin |
---|---|---|
Alix Ventures
Alix Ventures Investment ManagersFinance Alix Ventures is an venture capital firm founded in 2019 by Chas Pulido. The firm is headquartered in San Francisco, California. | Private Equity Investor | - |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Directeur/Bestuurslid | 01-07-2021 |
Eerdere bekende functies van Grace Larry
Bedrijven | Functie | Einde |
---|---|---|
AMGEN INC. | Directeur/Bestuurslid | 01-04-2021 |
NOVARTIS AG | Corporate Officer/Principal | 01-04-2013 |
Opleiding van Grace Larry
Northwestern University School of Law | Graduate Degree |
Kellogg School of Management | Masters Business Admin |
University of California, Berkeley | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
AMGEN INC. | Health Technology |
NOVARTIS AG | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Alix Ventures
Alix Ventures Investment ManagersFinance Alix Ventures is an venture capital firm founded in 2019 by Chas Pulido. The firm is headquartered in San Francisco, California. | Finance |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Health Technology |